Genomic studies revealed that patients with high-risk NB frequently harbored recurrent MYCN amplification (37%), TERT rearrangements (23%), and alpha thalassemia mental retardation X-linked (ATRX) mutations or deletions (11%) [1, 2]. The gene discussed is MYCN; the disease is neuroblastoma.